Introduction
The double-strand RNA (dsRNA)-dependent protein kinase (PKR) is a ubiquitously expressed serin-threonine kinase that is dramatically induced by interferon-γ. Consisting of two dsRNA-binding domains at its N-terminus and a conserved kinase domain at its Cterminus, PKR is activated by binding to dsRNA or interaction with other proteins, which leads to dimerization and autophosphorylation of PKR (Williams, 2001) . Activated PKR phosphorylates the alpha subunit of protein synthesis initiation factor eIF2 (eIF2α), leading to inhibition of protein synthesis and eliciting antivirus and antitumor activities. Moreover, PKR has been reported to induce apoptosis by modulating activities of eIF2α (Der et al., 1997) , NF-κB (Gil et al., 1999) , ATF-3 (Hai and Hartman, 2001) , and p53 (Garcia et al., 2006) . Because of this, activation of PKR in tumor cells has been proposed as a modality for cancer treatment. Indeed, we and others have previously found that adenoviral-mediated overexpression of the melanoma differentiation-associated gene 7 (Ad-mda7) induced apoptosis in cancer cells by activation of PKR (Emdad et al., 2007; Pataer et al., 2002) .
Blocking PKR activation inhibited Ad-mda7-induced apoptosis, suggesting a critical role of PKR activation in such apoptosis. Similarly, PKR plays an essential role in apoptosis induced by tumor necrosis factor (Yeung et al., 1996) and oncolytic viruses (Gaddy and Lyles, 2007) .
Furthermore, tumor-specific activation of PKR by dsRNA molecules induced apoptosis of glioblastoma cells in vitro and suppressed glioblastoma in vivo (Shir and Levitzki, 2002) .
Interestingly, expression and autophosphorylation of PKR were increased in several types of cancer, including melanoma, colon cancer, and breast cancer (Kim et al., 2000; 2002) .
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The fact that PKR plays an important role in apoptosis induction and that its expression is increased in several types of cancers led us to hypothesize that a balance between increased PKR expression and increased anti-apoptosis molecules may be established in cancer cells, preventing them from undergoing apoptosis, and that small molecules that can break this balance might be useful for selective induction of apoptosis in cancer cells that overexpress PKR. To search for such small compounds, we used PKR wild-type (PKR +/+ ) and PKR- Cytotoxicity Studies. The viability of the cell lines was determined using the sulforhodamine B (SRB) assay, as previously described (Pauwels et al., 2003) . Cells (2-8 ×10 3 cells in 100 μ l of culture medium per well) were seeded in 96-well flat-bottomed plates and treated the next day with the agents at the indicated concentrations. After the indicated times, cells were fixed with trichloroacetic acid. The protein was stained with sulforhodamine B, and the optical density at 570 nm was determined. Relative cell viability was determined by setting the viability of the control cells (exposed only to DMSO) at 100%
and comparing the viability of the treated cells to that of the controls. The experiments were performed at least three times for each cell line. glycerol] containing 1× proteinase-inhibitor cocktail (Roche Diagnostics). The lysates were spun at 14,000 g in a microcentrifuge at 4°C for 10 minutes, and the resulting supernatants were used as whole-cell extracts. Protein concentrations were determined by using the BCA protein assay kit (Pierce, Rockford, IL). Equal amounts (30-50 μ g) of proteins were used for immunoblotting as described previously (Teraishi et al., 2003) .
Flow
Viruses and Titer Analysis. Oncolytic vaccinia virus has also been described previously (Guo et al., 2005) . vSP is a modified vaccinia virus that has deletions in two antiapoptosis serpin genes, SPI-1 and SPI-2 (Guo et al., 2005) . Adenoviruses expressing the dominant- Anderson Cancer Center as previously described (Fang et al., 1998) . The titer used for vaccinia virus in this study was the infectious units (IUs) determined by the TCID 50 (50% tissue culture infectious dose) assay (Fang et al., 1998) .
Statistical Analysis. Differences among the treatment groups were assessed by ANOVA using StatSoft statistical software (StatSoft, Tulsa, OK); p < 0.05 was regarded as significant. (Fig. 2b, 2c) . At 24 and 72 h after treatment with 10 μ M BEPP, 32.3% and 84.6% of MEF/PKR +/+ cells, respectively, were in sub-G1 phase.
Results

Library Screening for Compounds with Differential Cytotoxic Effects for MEF/PKR
Induction of Apoptosis in MEF/PKR +/+ by BEPP
Similarly, dramatic increases of the sub-G1 portion in MEF/PKR +/+ cells were observed at doses of 5 and 10 μ M. In contrast, only background levels (less than 5%) of sub-G1 cells were seen in MEF/PKR -/-cells under the same treatment conditions (Fig. 2b, 2c ). These results demonstrated that BEPP can induce apoptosis in MEF/PKR +/+ in a dose-dependent and time-dependent manner.
PKR Activation Is Required for BEPP-Induced Apoptosis
The induction of apoptosis observed in MEF/PKR +/+ but not MEF/PKR -/-cells suggested a role for PKR pathways in BEPP-induced apoptosis. We therefore investigated the changes in PKR, eIF2α, and cyclin D1 after BEPP treatment. Cells were treated with various concentrations of BEPP for 72 h, and then lysates were analyzed by Western blotting.
Control cells were treated with DMSO. The results showed that treatment of MEF/PKR +/+ cells with BEPP increased the amounts of phosphorylated PKR and eIF2α, which were easily detectable at the concentration of 2.5 μ mol/L (Fig. 3) . Levels of phosphorylated PKR after treatment of BEPP at the dose of 2.5 and 10 μ mol/L were increased about 2 and 3.5 folds respectively when determined by a densitometric analysis and normalized with that of β-actin (Supplementary Figure 1) . In contrast, treatment with BEPP did not result in detectable changes of phosphorylated eIF2α in MEF/PKR -/-cells. Cyclin D1 was decreased after BEPP treatment in MEF/PKR +/+ cells, which was consistent with eIF2α phosphorylation because phosphorylation of eIF2α results in the inhibition of cyclin D1 translation (Brewer and Diehl, 2000) . We also examined the activation of the MAPKs JNK, p38, and AKT after BEPP treatment (Fig. 3) (Fig. 4a) . Moreover, pretreatment of Ad/PKR Δ 6 blocked BEPP-induced PKR activation, as evidenced by marked reductions of phosphorylated PKR compared with that of Ad/LacZ-pretreated cells (Fig. 4b) . This result indicates that PKR activation is critical for BEPP-induced apoptosis.
PKR-Overexpressing Cancer Cells Are More Sensitive to BEPP
We then investigated whether levels of PKR expression may affect the susceptibility to BEPP. For this purpose, we evaluated expression of PKR in the human lung cancer cell lines H1299, H460, H226B, and A549 and in normal human bronchial epithelial (HBE) cells by Western blot analysis. The results showed that H226B cells had higher PKR expression compared with the other four cell lines (Fig. 5a ). Next, we determined cell viability of these five cell lines after treatment with BEPP at various concentrations for 72 h. The result showed that BEPP inhibited growth of all five cell lines in a dose-dependent manner (Fig.   5b ). The IC 50 values at 72 h for H226B, H460, A549, H1299 and HBE were 4.6, 11.5, 13.8, 15.8, and 15.6 μ mol/L, respectively. H226B, which has higher PKR expression than other four cell lines, was more sensitive to BEPP. This result indicates that BEPP or its active analogues might be useful for treatment of cancers with overexpression of PKR. μ mol/L (data not shown). The virus yield in the BEPP pretreatment group was much lower than in the DMSO group or the BECC group (p < 0.01): at day 4 to day 6, the difference was about 100 fold (Fig. 6a) . A similar result was observed when vaccinia virus and BEPP were added to HeLa cells at the same time (Supplement Fig. 2) . We also harvested cell lysates after infection with vSP for 4 days and tested the status of PKR and eIF2α. BEPP pretreatment resulted in a dramatic increase of phosphorylated PKR and eIF2α (Fig. 6b) .
Inhibition of Vaccinia Virus Replication by BEPP
Discussion
PKR is one of the well-characterized molecules induced by INF-γ. The well-known downstream targets of PKR include eIF-2α and the regulatory subunit of protein phosphatase 2A (PP2A), B56α. Both eIF-2α and B56α, when phosphorylated by PKR, lead to inhibition of protein synthesis, which is critical for PKR-mediated inhibition of virus replication.
Whereas inhibition of protein synthesis may contribute to PKR-mediated apoptosis, other mechanisms of PKR-mediated apoptosis have also been reported. In addition to inhibition of protein synthesis, PKR has been reported to increase the expression of pro-apoptotic genes, including Fas and Bax (Balachandran et al., 1998) . PKR has also been reported to induce apoptosis by activation of FADD/caspase 8 (Balachandran et al., 1998) , by interaction and phosphorylation of p53 and enhancing its transcriptional activity (Cuddihy et al., 1999a; Cuddihy et al., 1999b) , and by modulating NFκB activities (Gil et al., 1999; Kumar et al., 1994 expression of a dominant-negative PKR can block BEPP-induced apoptosis, demonstrating that BEPP-induced apoptosis is PKR dependent. The fact that BEPP treatment led to an increase of phosphorylation in eIF2α and increased expression of Bax was also consistent with previous reports of PKR-mediated apoptosis (Der et al., 1997; Gil et al., 2002) .
Treatment with BEPP resulted in an increase of phosphorylated PKR but not basal PKR, suggesting that the major mechanism of action is activating, but not induction, of PKR.
PKR is known to be activated by binding with dsRNA, a vital cellular antiviral response upon viral infection. In addition to activation by virus infection, PKR is activated through various other stimuli, including cytokine, growth factor, and stress signals. It has been reported that PACT, a cellular protein, acts as a protein activator of PKR in response to diverse stress signals such as serum starvation and peroxide or arsenite treatment (Patel and Sen, 1998; Patel et al., 2000) . Following exposure of cells to these stress agents, PACT is phosphorylated and associates with PKR with increased affinity. Heterodimerization of PACT with PKR leads to PKR activation in the absence of dsRNA (Li et al., 2006) .
Moreover, PACT-mediated activation of PKR leads to enhanced eIF2α phosphorylation followed by apoptosis (Patel et al., 2000; Li et al., 2006) . Whether PACT is involved in BEPP-mediated PKR activation is not yet clear. Nevertheless, our data suggested treatment with BEPP induced apoptosis in a PKR-dependent manner, as was evidenced by activation of caspase 3 and dramatic increased of apoptotic cells determined flow cytometric assay.
However, PKR is known to play important role in other cell death mechanisms, such as autophagy (Talloczy et al., 2002) . Whether autophagy is also involved in BEPP-induced cell death remains to be determined.
A small compound that can induce PKR-dependent apoptosis may have two applications. First, such a compound may be useful for treatment of cancers with overexpression of PKR. It has been reported that PKR expression was increased in melanoma, colon cancer, and breast cancer (Kim et al., 2000; 2002) . More recently, we have found that PKR played a role in radioresistance (von Holzen et al., 2007) . The finding was consistent with previous reports that PKR activation can inhibit virus replication, such as that of vaccinia virus, HIV, hepatitis C virus, influenza virus, varicellazoster, and herpes simplex virus Bergmann et al., 2000; Chang et al., 2006; Desloges et al., 2005; Goodman et al., 2007; Muto et al., 1999; Pflugheber et al., 2002; Smith et al., 2006 Whole-cell lysates were analyzed for total and active (phosphorylated) PKR, eIF2α, and cyclin D1, total and active (phosphorylated) AKT, active p38, and JNK by Western blotting.
β -actin was used as a loading control. Cell lysates were harvested at the indicated time points and titrated using the TCID 50 method.
The virus yield in the BEPP group was much lower than in the DMSO or BECC group (p < 0.01) at day 4 to day 6. b, Cell lysates were harvested after infection of vSP for 4 days. The
